162 related articles for article (PubMed ID: 17533574)
1. Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2.
Pomplun D; Florian S; Schulz T; Pfeiffer AF; Ristow M
Horm Metab Res; 2007 May; 39(5):336-40. PubMed ID: 17533574
[TBL] [Abstract][Full Text] [Related]
2. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor Stat3 is dispensable for pancreatic beta-cell development and function.
Lee JY; Hennighausen L
Biochem Biophys Res Commun; 2005 Sep; 334(3):764-8. PubMed ID: 16026757
[TBL] [Abstract][Full Text] [Related]
4. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
5. Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice.
Gorogawa S; Fujitani Y; Kaneto H; Hazama Y; Watada H; Miyamoto Y; Takeda K; Akira S; Magnuson MA; Yamasaki Y; Kajimoto Y; Hori M
Biochem Biophys Res Commun; 2004 Jul; 319(4):1159-70. PubMed ID: 15194489
[TBL] [Abstract][Full Text] [Related]
6. RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function.
Lee JY; Ristow M; Lin X; White MF; Magnuson MA; Hennighausen L
J Biol Chem; 2006 Feb; 281(5):2649-53. PubMed ID: 16326700
[TBL] [Abstract][Full Text] [Related]
7. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.
Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174
[TBL] [Abstract][Full Text] [Related]
8. Beta cells within single human islets originate from multiple progenitors.
Scharfmann R; Xiao X; Heimberg H; Mallet J; Ravassard P
PLoS One; 2008; 3(10):e3559. PubMed ID: 18958289
[TBL] [Abstract][Full Text] [Related]
9. Caveats and considerations for performing pancreas-specific gene manipulations in the mouse.
Magnuson MA; Burlison JS
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():5-13. PubMed ID: 17919173
[TBL] [Abstract][Full Text] [Related]
10. Effects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets.
Pascal SM; Guiot Y; Pelengaris S; Khan M; Jonas JC
Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E92-102. PubMed ID: 18413670
[TBL] [Abstract][Full Text] [Related]
11. Normal islet vascularization is dispensable for expansion of beta-cell mass in response to high-fat diet induced insulin resistance.
Toyofuku Y; Uchida T; Nakayama S; Hirose T; Kawamori R; Fujitani Y; Inoue M; Watada H
Biochem Biophys Res Commun; 2009 Jun; 383(3):303-7. PubMed ID: 19336220
[TBL] [Abstract][Full Text] [Related]
12. Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase.
Zhang H; Fujitani Y; Wright CV; Gannon M
Genesis; 2005 Jul; 42(3):210-7. PubMed ID: 15986486
[TBL] [Abstract][Full Text] [Related]
13. The transcription factors Stat5a/b are not required for islet development but modulate pancreatic beta-cell physiology upon aging.
Lee JY; Gavrilova O; Davani B; Na R; Robinson GW; Hennighausen L
Biochim Biophys Acta; 2007 Sep; 1773(9):1455-61. PubMed ID: 17599554
[TBL] [Abstract][Full Text] [Related]
14. A novel technique for temporally regulated cell type-specific Cre expression and recombination in the pituitary gonadotroph.
Naik K; Pittman I; Wolfe A; Miller RS; Radovick S; Wondisford FE
J Mol Endocrinol; 2006 Aug; 37(1):63-9. PubMed ID: 16901924
[TBL] [Abstract][Full Text] [Related]
15. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
Zhou J; Cheng X; Lu YX; Huang CF; Yang X
Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice.
Cantley J; Choudhury AI; Asare-Anane H; Selman C; Lingard S; Heffron H; Herrera P; Persaud SJ; Withers DJ
Diabetologia; 2007 Jun; 50(6):1248-56. PubMed ID: 17393136
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells.
Tamarina NA; Roe MW; Philipson L
Islets; 2014; 6(1):e27685. PubMed ID: 25483876
[TBL] [Abstract][Full Text] [Related]
18. Modulation of endocrine pancreas development but not beta-cell carcinogenesis by Sprouty4.
Jäggi F; Cabrita MA; Perl AK; Christofori G
Mol Cancer Res; 2008 Mar; 6(3):468-82. PubMed ID: 18337453
[TBL] [Abstract][Full Text] [Related]
19. Hexosamines regulate sensitivity of glucose-stimulated insulin secretion in beta-cells.
Cooksey RC; Pusuluri S; Hazel M; McClain DA
Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E334-40. PubMed ID: 16188910
[TBL] [Abstract][Full Text] [Related]
20. Rearrangement of a conditional allele regardless of inheritance of a Cre recombinase transgene.
Cochrane RL; Clark SH; Harris A; Kream BE
Genesis; 2007 Jan; 45(1):17-20. PubMed ID: 17211878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
